
About Emphaatic Pharmaceuticals Private Limited
Data last updated:
Emphaatic Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52311MH2012PTC228837. Its GSTIN is 27AADCE0024E1ZB (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Hasmukhray Ottamchand Punatar and Damayanti Mahendra Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 27 Maruthi Cresant Plot Number 16A Sector 14 Kalamboli, Navi Mumbai, Maharashtra, India – 410218.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.69 Lakh. For the same year it recorded a net profit of ₹98,325 (net margin 4.3%) and EBITDA of ₹3.85 Lakh (EBITDA margin 17%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emphaatic.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address27 Maruthi Cresant Plot Number 16A Sector 14 Kalamboli, Navi Mumbai, Maharashtra, India – 410218
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Emphaatic Pharmaceuticals Private Limited
The main business activity of Emphaatic Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Emphaatic Pharmaceuticals Private Limited FY 2025 filings available
Emphaatic Pharmaceuticals Private Limited reported revenue of ₹22.69 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Emphaatic Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years. EBITDA rose 252% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Emphaatic Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.85 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹98,325 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Emphaatic Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Emphaatic Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Symira Pharmaceuticals Private Limited | ₹22.78 Lakh (FY 2025) | •••• | •••• | -32.0% | •••• | Lucknow, Uttar Pradesh, India |
| Muse Healthcare Private Limited | ₹22.76 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Lucknow, Uttar Pradesh, India |
| Uniswen Pharmaceuticals Private Limited | ₹22.76 Lakh (FY 2020) | •••• | •••• | 34.0% | •••• | Pune, Maharashtra, India |
| Devann Pharmaceuticals Private Limited | ₹22.75 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Agra, Uttar Pradesh, India |
| Inocta Pharmaceuticals Private Limited | ₹22.7 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Patna, Bihar, India |
| Emphaatic Pharmaceuticals Private Limited this company | ₹22.69 Lakh (FY 2025) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Hummock Pharmaceuticals Private Limited | ₹22.64 Lakh (FY 2020) | •••• | •••• | •••• | Bhopal, Madhya Pradesh, India | |
| Navante Pharmaceuticals Private Limited | ₹22.6 Lakh (FY 2025) | •••• | •••• | •••• | Vijayawada, Andhra Pradesh, India | |
| Midsun Pharmaceuticals Private Limited | ₹22.59 Lakh (FY 2025) | •••• | •••• | 62.0% | •••• | Yeshwanthpur, Karnataka, India |
| Nilesh Pharmachem Private Limited | ₹22.58 Lakh (FY 2016) | •••• | •••• | -83.0% | •••• | Mumbai, Maharashtra, India |
| Rokro Pharma Private Limited | ₹22.56 Lakh (FY 2025) | •••• | •••• | 7247.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Emphaatic Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals Private Limited is audited by MOTANI & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MOTANI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hasmukhray Ottamchand Punatar Also directs: Venus Sales Corporation Private Limited, Diab Care LLP | Director | 14 Oct 2013 | 12 Years 11 Months | Current |
| Damayanti Mahendra Patel | Director | 14 Oct 2013 | 12 Years 11 Months | Current |
| Gaurang Hasmukhray Punatar Also directs: Venus Sales Corporation Private Limited | Director | 14 Oct 2013 | 12 Years 11 Months | Current |
Ownership and Shareholding of Emphaatic Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Emphaatic Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Emphaatic Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals Private Limited has 8 board changes on record since 2013: 3 appointments and 5 cessations. The latest: Ashok R Yadav ceased to be Director on 01 Sep 2020.
Credit Ratings, Litigation & Regulatory Alerts for Emphaatic Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Emphaatic Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Emphaatic Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCE0024E1ZB | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Emphaatic Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emphaatic Pharmaceuticals Private Limited
Emphaatic Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 March 2012 (14+ years old) and is registered under CIN U52311MH2012PTC228837.
Emphaatic Pharmaceuticals reported revenue of ₹22.69 Lakh for FY 2025.
Emphaatic Pharmaceuticals has 3 current directors:
- Hasmukhray Ottamchand Punatar - Director
- Damayanti Mahendra Patel - Director
- Gaurang Hasmukhray Punatar - Director
Emphaatic Pharmaceuticals reported a net profit of ₹98,325 (net margin 4.3%) and EBITDA of ₹3.85 Lakh (EBITDA margin 17%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Emphaatic Pharmaceuticals is -10% over three years and -11% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Emphaatic Pharmaceuticals is 27AADCE0024E1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Emphaatic Pharmaceuticals is U52311MH2012PTC228837. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emphaatic Pharmaceuticals was incorporated on 28 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Emphaatic Pharmaceuticals by revenue are Symira Pharmaceuticals Private Limited, Muse Healthcare Private Limited, Uniswen Pharmaceuticals Private Limited, Devann Pharmaceuticals Private Limited, Inocta Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Ashok R Yadav ceased to be Director on 01 Sep 2020. Preeti Bhaurao Chavan ceased to be Director on 01 Sep 2020. Sachin Tukaram Mali ceased to be Director on 01 Sep 2020. Emphaatic Pharmaceuticals has 8 board changes on record in total.
Emphaatic Pharmaceuticals can be reached through the website emphaatic.com. Its registered office is in Navi Mumbai, Maharashtra, India.